Enoxaparin Sodium Injection
Product Images NDC 16714-006

38 FDA label images from Northstar Rx Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 38 technical images submitted to the FDA as part of the official labeling for Enoxaparin Sodium (NDC 16714-006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure A (Eno0d 0001 01)

Figure A (Eno0d 0001 01)
An instructional diagram showing hands removing a cap from the needle of a syringe, likely demonstrating preparation steps for subcutaneous injection.*
FDA Label Image

Figure B (Eno0d 0001 02)

Figure B (Eno0d 0001 02)
An instructional line drawing showing a hand administering a subcutaneous injection with a syringe into a person's skin, indicated by an arrow pointing to the injection site.*
FDA Label Image

Figure C (Eno0d 0001 03)

Figure C (Eno0d 0001 03)
An instructional diagram showing a hand holding a syringe and injecting a substance subcutaneously into a bent arm. An arrow indicates the direction of the injection.*
FDA Label Image

Figure D (Eno0d 0001 04)

Figure D (Eno0d 0001 04)
An instructional illustration showing a hand holding a prefilled syringe of Enoxaparin Sodium injection. The syringe is held with the thumb positioned near the plunger, indicated by an arrow showing the direction to push or pull, likely demonstrating preparation or administration technique for subcutaneous injection.*
FDA Label Image

Figure E (Eno0d 0001 05)

Figure E (Eno0d 0001 05)
An instructional illustration showing a gloved hand disposing of a used syringe into a biohazard sharps container labeled 'BIOHAZARD.' The image demonstrates safe disposal of injection needles to prevent biohazard risks.*
FDA Label Image

Structural Formula (Eno0d 0001 06)

Structural Formula (Eno0d 0001 06)
Chemical structure diagram of Enoxaparin Sodium, showing a polysaccharide chain with repeating disaccharide units. Substituents R1 and R2 represent variable groups, where R1 is hydrogen or sulfonate sodium and R2 is sulfonate sodium or acetyl methyl group.*
FDA Label Image

Structural Formula (Eno0d 0001 07)

Structural Formula (Eno0d 0001 07)
Chemical structure diagram illustrating the molecular composition of Enoxaparin Sodium. It features polysaccharide units with details on substitution groups, including sodium (Na), hydroxyl (OH), and sulfate (NHSO3Na) groups, and variable polymer chain lengths denoted by n values.*
FDA Label Image

Figure 1 (Eno0d 0001 08)

Figure 1 (Eno0d 0001 08)
A forest plot chart depicting relative risk comparisons between Enoxaparin Sodium and UFH across various patient subgroups. The plot shows relative risk values, number of patients per subgroup, and percentage risk for both treatments, indicating a trend favoring Enoxaparin Sodium in most subgroups with risk reduction percentages listed for each.*
FDA Label Image

Figure 2 (Eno0d 0001 09)

Figure 2 (Eno0d 0001 09)
A hazard distribution function graph comparing Enoxaparin Sodium injection and UFH over time, specifically time to death or myocardial re-infarction in days. The chart includes a main plot for up to 30 days and an inset showing data at 1 year. Enoxaparin shows a lower hazard distribution compared to UFH throughout the timeframe, with number at risk counts provided below the x-axis for both treatments at various time points.*
FDA Label Image

Syringe Parts (Enox Ifu Parts)

Syringe Parts (Enox Ifu Parts)
An instructional diagram showing the use of a syringe for injection. The left side illustrates the syringe before use with labeled parts: plunger rod, needle, and needle cap. The right side shows the syringe after use, with the plunger rod depressed and a protective sleeve covering the needle. This visual aids in safe handling and disposal of the injection device.*
FDA Label Image

Figure A (Enox Ifu A)

Figure A (Enox Ifu A)
An instructional illustration showing components related to Enoxaparin Sodium injection use. It includes a sharps disposal container, alcohol wipes, a small adhesive bandage, a cotton ball or gauze, and a prefilled syringe labeled for subcutaneous injection.*
FDA Label Image

Figure B (Enox Ifu B)

Figure B (Enox Ifu B)
An instructional illustration showing hands peeling the backing off a syringe or injection device, likely demonstrating preparation for subcutaneous injection of Enoxaparin Sodium injection.*
FDA Label Image

Figure C (Enox Ifu C)

Figure C (Enox Ifu C)
Illustration of an Enoxaparin Sodium prefilled syringe for subcutaneous injection. The image shows the syringe body with a plunger, a protective cap over the needle area, and an expiration date marked on the barrel. It is intended for dosing and administration guidance.*
FDA Label Image

Figure D (Enox Ifu D)

Figure D (Enox Ifu D)
Illustration of a prefilled syringe for Enoxaparin Sodium injection showing the clear liquid medication inside. The syringe includes a plunger and protective cap, designed for subcutaneous administration.*
FDA Label Image

Figure E (Enox Ifu E)

Figure E (Enox Ifu E)
An instructional illustration showing the lower abdominal area with two shaded rectangular regions on either side, indicating recommended subcutaneous injection sites for enoxaparin sodium injection. The diagram emphasizes proper injection placement around the navel area.*
FDA Label Image

Figure F (Enox Ifu F)

Figure F (Enox Ifu F)
An instructional illustration showing a person injecting Enoxaparin Sodium subcutaneously into the abdomen. The image focuses on the injection site on the lower abdominal area, demonstrating the correct placement for the subcutaneous injection.*
FDA Label Image

Figure G (Enox Ifu G)

Figure G (Enox Ifu G)
An instructional illustration showing two hands assembling or preparing a syringe by attaching or detaching a cap to or from the syringe tip. Arrows indicate the direction of movement for the cap relative to the syringe.*
FDA Label Image

Figure H (Enox Ifu H)

Figure H (Enox Ifu H)
An instructional illustration showing a hand holding a syringe with a plunger being pushed down. An arrow points downward, indicating the action to 'Set your dose,' suggesting dose adjustment or administration step for an injection.*
FDA Label Image

Figure I (Enox Ifu I)

Figure I (Enox Ifu I)
An instructional illustration showing a person's hand pinching the skin on the abdomen, demonstrating the typical technique for subcutaneous injection administration.*
FDA Label Image

Figure J (Enox Ifu J)

Figure J (Enox Ifu J)
Instructional illustration depicting a person administering a subcutaneous injection of Enoxaparin Sodium in the abdominal area. The syringe is shown held at a 90-degree angle to the skin, indicating the proper injection technique for this dosage form.*
FDA Label Image

Figure K (Enox Ifu K)

Figure K (Enox Ifu K)
Black and white instructional illustration showing a person administering a subcutaneous injection in the abdominal area, holding a syringe parallel to the skin. An arrow indicates the direction of injection placement on the lower abdomen.*
FDA Label Image

Figure L (Enox Ifu L)

Figure L (Enox Ifu L)
An instructional illustration depicting the administration of a subcutaneous injection in the abdominal area. The image shows a person pinching the skin near the navel with one hand while holding a syringe in the other hand, preparing for injection.*
FDA Label Image

Figure M (Enox Ifu M)

Figure M (Enox Ifu M)
An instructional drawing showing a hand holding a syringe labeled with a protective sleeve. The syringe plunger is being pressed, indicated by an arrow and the word 'CLICK,' illustrating the proper technique for administering a subcutaneous injection.*
FDA Label Image

Figure N (Enox Ifu N)

Figure N (Enox Ifu N)
An instructional illustration showing a hand disposing of an Enoxaparin Sodium Injection Syringe into a labeled Sharps Disposal Container. The image highlights the syringe, needle cap, and the sharps container as part of safe disposal instructions.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 30 mg Blister Pack Northstar Label (Eno0d 0001 10 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 30 mg Blister Pack Northstar Label (Eno0d 0001 10 V4)
Label for Enoxaparin Sodium Injection, USP, 30 mg per 0.3 mL, a subcutaneous injection. The label shows dosage strength and volume, NDC 16714-006-01, and the labeler NorthStar Rx LLC. It includes usage instructions, warnings, and is marked Rx only.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 30 mg Northstar Carton (Eno0d 0001 11 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 30 mg Northstar Carton (Eno0d 0001 11 V4)
Packaging label for Enoxaparin Sodium Injection USP, 30 mg per 0.3 mL, a subcutaneous injection. The label indicates the product contains 10 single-dose prefilled syringes with an automatic safety device. The labeler is NorthStar Rx LLC. The packaging includes storage and usage information, bar code, and manufacturing details.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 40 mg Blister Pack Northstar Label (Eno0d 0001 12 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 40 mg Blister Pack Northstar Label (Eno0d 0001 12 V4)
Label for Enoxaparin Sodium Injection, USP, 40 mg per 0.4 mL, a subcutaneous injection by NorthStar Rx LLC. The label includes dosage strength, NDC 16714-016-01, barcode, usage instructions, and warnings in a primarily white and yellow design.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 40 mg Northstar Carton (Eno0d 0001 13 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 40 mg Northstar Carton (Eno0d 0001 13 V4)
Packaging label for Enoxaparin Sodium Injection, USP, 40 mg per 0.4 mL, by NorthStar Rx LLC. The label indicates a box of 10 single-dose prefilled syringes with automatic safety device, for subcutaneous use. It includes storage instructions, manufacturing details from Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd., and a barcode.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 60 mg Blister Pack Northstar Label (Eno0d 0001 14 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 60 mg Blister Pack Northstar Label (Eno0d 0001 14 V4)
Label for Enoxaparin Sodium Injection, USP, 60 mg per 0.6 mL, by NorthStar Rx LLC. The label includes NDC 16714-026-01, usage as a subcutaneous single-dose injection with an anticoagulant dispensing device, and dosage instructions. It features barcodes, lot and expiration date fields, and safety information.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 60 mg Northstar Carton (Eno0d 0001 15 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 60 mg Northstar Carton (Eno0d 0001 15 V4)
Enoxaparin Sodium Injection, USP 60 mg per 0.6 mL in single-dose prefilled syringes with automatic safety device. The label indicates subcutaneous use, with packaging for 10 syringes of 0.6 mL each. Manufactured for NorthStar Rx LLC, the packaging notes storage instructions and absence of preservatives and natural rubber latex.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 80 mg Blister Pack Northstar Label (Eno0d 0001 16 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 80 mg Blister Pack Northstar Label (Eno0d 0001 16 V4)
Label for Enoxaparin Sodium Injection, USP, 80 mg per 0.8 mL, a subcutaneous injection. The label includes the NDC number 16714-036-01 and indicates it is a prescription drug by NorthStar Rx LLC. The text provides usage instructions and cautions, along with a barcode and spaces for lot and expiration date.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 80 mg Northstar Carton (Eno0d 0001 17 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 80 mg Northstar Carton (Eno0d 0001 17 V4)
Packaging label for Enoxaparin Sodium Injection, USP, 80 mg per 0.8 mL, for subcutaneous use. The carton holds 10 single-dose prefilled syringes with automatic safety device. Labeler is NorthStar Rx LLC. The label includes storage instructions, manufacturing information, and indicates the product is sterile and preservative-free.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 100 mg Blister Pack Northstar Label (Eno0d 0001 18 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 100 mg Blister Pack Northstar Label (Eno0d 0001 18 V4)
Label for Enoxaparin Sodium Injection, USP, 100 mg per mL, intended for subcutaneous use. The label includes dosage strength, route of administration, and warnings regarding use with autoinjector devices. It is marked Rx only and labeled by NorthStar Rx LLC.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 100 mg Northstar Carton (Eno0d 0001 19 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 100 mg Northstar Carton (Eno0d 0001 19 V4)
Packaging label for Enoxaparin Sodium Injection, USP 100 mg per mL for subcutaneous use. The carton contains 10 single-dose prefilled syringes with automatic safety devices. Labeler is NorthStar Rx LLC, manufactured by Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd. in China. Includes storage instructions and barcodes.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 120 mg Blister Pack Northstar Label (Eno0d 0001 20 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 120 mg Blister Pack Northstar Label (Eno0d 0001 20 V4)
Label for Enoxaparin Sodium Injection, USP, 120 mg per 0.8 mL, manufactured by NorthStar Rx LLC. The label indicates the product is for subcutaneous use with a single-dose prefilled syringe and includes directions for use, warnings, and a barcode. The NDC is 16714-056-01.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 120 mg Northstar Carton (Eno0d 0001 21 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 120 mg Northstar Carton (Eno0d 0001 21 V4)
Packaging label for Enoxaparin Sodium Injection, USP, 120 mg per 0.8 mL, subcutaneous injection. The label indicates it contains 10 single-dose prefilled syringes with automatic safety devices. The product is manufactured for NorthStar Rx LLC and displays storage and usage instructions, warnings, and a barcode.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 150 mg Blister Pack Northstar Label (Eno0d 0001 22 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 150 mg Blister Pack Northstar Label (Eno0d 0001 22 V4)
Label for Enoxaparin Sodium Injection USP 150 mg per mL from NorthStar Rx LLC. The label includes the NDC 16714-066-01 and indicates the product is for subcutaneous use as a single-dose prefilled syringe. Additional regulatory and barcode information is present on the right side of the label.*
FDA Label Image

Principal Display Panel – Enoxaparin Sodium Injection, Usp 150 mg Northstar Carton (Eno0d 0001 23 V4)

Principal Display Panel – Enoxaparin Sodium Injection, Usp 150 mg Northstar Carton (Eno0d 0001 23 V4)
Packaging label for Enoxaparin Sodium Injection, USP 150 mg per mL, 10 x 1 mL single-dose prefilled syringes with automatic safety device. The label indicates it is for subcutaneous use and is manufactured for NorthStar Rx LLC. The storage and handling instructions, warning, and manufacturing details are also included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.